Response to brentuximab vedotin in advanced stage MF/Sézary syndrome with low CD-30 expression: “real-life” data of the German Cutaneous Lymphoma Network

European Journal of Cancer(2021)

引用 0|浏览3
暂无评分
关键词
Brentuximab,advanced CTCL,CD30,therapy,mycosis fungoides,Sézary syndrome,real-life data,German Cutaneous Lymphoma Network
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要